EU agency questions berberine safety, could impact US market
news · 2026-07-03 · SupplySide Supplement Journal
The European Food Safety Authority (EFSA) is close to ruling that it can't establish a safe intake level for berberine. This move could restrict sales in the EU and potentially pressure US regulators to re-evaluate the popular supplement, known for its blood sugar and metabolic benefits.
Sabin's take. The EFSA's take on berberine isn't surprising – it mirrors the ongoing regulatory squint at supplements across the board, especially those with drug-like effects. Berberine, often lauded as 'nature's Ozempic' for its GLP-1-like metabolic improvements and blood sugar regulation, is now squarely in the crosshairs. The mechanism here is clear: when a supplement performs too well, regulators start treating it like a pharmaceutical, demanding pharmaceutical-level safety and efficacy data. If the EU makes a formal finding, the domino effect is real: expect US retailers and even the FDA to start asking harder questions, potentially removing products or adding stern warnings. This means consumers who rely on berberine for metabolic health might see their go-to brands disappear or reformulate. Watch for smaller, less-resourced brands to get squeezed first, while larger players might invest in the costly trials needed to satisfy a new regulatory baseline.
#policy #supplement #nutrition #glp1 #longevity #nervous-system